VivoSim Labs, Inc. Share Price & Technical Analysis
VIVS · $1.36 (+1.49%)
Healthcare / Biotechnology
$1.36
+1.49%
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidat…
Price chart
Seasonality
May has 0 positive and 3 negative years (last 5 years shown)
0% return in May, -8% avg return in past 3 year May month.
9% return in 2026, -28% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 53% | -21% | -30% | 8% | 0% | – | – | – | – | – | – | – | 9% |
| 25 | -26% | 77% | -69% | -9% | -10% | -12% | 27% | 33% | 21% | -7% | -12% | -18% | -5% |
| 24 | -8% | -2% | 2% | 3% | 0% | -24% | -26% | 6% | -16% | -13% | 7% | -5% | -77% |
| 23 | 11% | 48% | -5% | -11% | -13% | -1% | 3% | -27% | 4% | -12% | 6% | -4% | -1% |
| 22 | -17% | 13% | 1% | -23% | -17% | -26% | 56% | -19% | -22% | -22% | -11% | -7% | -94% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$3.85M
P/E ratio
0.76
52W high
$5.30
52W low
$1.22
Volume
37,335
Beta
1.41
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is VivoSim Labs, Inc. share price today?
- VivoSim Labs, Inc. (VIVS) last traded around $1.36 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does VIVS have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for VIVS. Download the app for real-time alerts.
- How can I analyze VivoSim Labs, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.